Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus

Infection

Volumn 30, Issue 5, 2002, Pages 320-322

  Lassker U ^a   Harder, T C ^a   Hufnagel, M ^b   Suttorp, M ^c  

^a UNIVERSITY OF KIEL   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHICKENPOX VACCINE; IMMUNOGLOBULIN; LIVE VACCINE; VARICELLA ZOSTER VACCINE;

ANAPLASTIC CARCINOMA; ARTICLE; BRAIN CANCER; CANCER CHEMOTHERAPY; CASE REPORT; CHICKENPOX; EPENDYMOMA; FEMALE; HUMAN; IMMUNE DEFICIENCY; MOLECULAR DYNAMICS; ONCOLOGY; PAPULAR SKIN DISEASE; PRESCHOOL CHILD; RASH; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION; WARD; WILD TYPE;

BRAIN NEOPLASMS; CHICKENPOX; CHICKENPOX VACCINE; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; EPENDYMOMA; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASM RECURRENCE, LOCAL; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK ASSESSMENT; VACCINATION;

EID: 0036389516     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-2158-2     Document Type: Article

References (15)

1. Feldman S, Lott L: Varicella in children with cancer: impact of antiviral therapy and prophylaxis. Pediatrics 1987; 80: 465-472.
2. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T: Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2: 1288-1290.
3. Gershon AA, Steinberg SP, Gelb L, Galasso G, Borkowsky W, LaRussa P, Farrara A: Live attenuated varicella vaccine. Efficacy for children with leukemia in remission. JAMA 1984; 252: 355-362.
4. Weibel RE, Neff BJ, Kuter BJ, Guess HA, Rothenberger CA, Fitzgerald AJ, Connor KA, McLean AA, Hilleman MR, Buynak EB, Scolnick ED: Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med 1984; 310: 1409-1415.
5. Black S, Shinefield H, Ray P, Lewis E, Hansen J, Schwalbe J, Coplan P, Sharrar R, Guess H: Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatr Infect Dis J 1999; 18: 1041-1046.
6. Huang W, Hussey M, Michel F: Transmission of varicella to a gravida via close contacts immunized with varicella-zoster vaccine. A case report. J Reprod Med 1999; 44: 905-907.
7. La Russa P, Steinberg S, Meurice F, Gershon A: Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. J Infect Dis 1997; 176: 1072-1075.
8. Salzman MB, Sharrar RG, Steinberg S, La Russa P: Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother [see comments]. J Pediatr 1997; 131: 151-154.
9. Diaz PS, Au D, Smith S, Amylon M, Link M, Arvin AM: Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. Pediatrics 1991; 87: 166-170.
10. Tsolia M, Gershon AA, Steinberg SP, Gelb L: Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. J Pediatr 1990; 116: 184-189.
11. Watson B, Keller PM, Ellis RW, Starr SE: Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity. J Infect Dis 1990; 162:794-799.
12. Kuehl J, Mueller HL, Berthold F, Kortmann RD, Deinlein F, Maas E, Graf N, Gnekow A, Scheurlen W, Gobel U, Wolff JE, Bamberg M, Kaatsch P, Kleihues P, Rating D, Sorensen N, Wiestler OD: Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT '88/'89. Klin. Paediatr. 1998; 210: 227-233.
13. Mori C, Takahara R, Toriyama T, Nagai T, Takahashi M, Yamanishi K: Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis. J Infect Dis 1998; 178: 35-38.
14. La Russa P, Steinberg S, Arvin A, Dwyer D, Burgess M, Menegus M, Rekrut K, Yamanishi K, Gershon A: Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J Infect Dis 1998; 178: 64-66.
15. Broyer M, Tete MJ, Guest G, Gagnadoux MF, Rouzioux C: Varicella and zoster in children after kidney transplantation: long-term results of vaccination. Pediatrics 1997; 99: 35-39.